Clinical Trial

Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.
Trial Details
NCT Number NCT07349459
Lead Sponsor Tanta University
Conditions Melatonin, Breast Cancer Patients Diagnosed, Vitamin D Concentration, Doxorubicin
Enrollment 90 participants
Start Date 2026-04-30
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-16